NCT02656498View on ClinicalTrials.gov

[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Alzheimer's DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases

Interventions

DRUG

[18F]THK-5351

Imaging for evaluating the accumulation of abnormal tau protein in the brain

Trial Locations (2)

05505

Asan Medical Center, Seoul

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors

collaborator

Korea Health Industry Development Institute

OTHER_GOV

collaborator

Samsung Medical Center

OTHER

lead

Jae Seung Kim

OTHER

NCT02656498 - [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease | Biotech Hunter | Biotech Hunter